Natural Capsules Ltd
Natural Capsules Ltd
P&F Pattern: Monthly Basis
Morning Star: Monthly Basis
*With Upside, Trail SL*
*Book Profit as per Risk Appetite*
Snapshot
Estab. in ‘93, Mfgs. Hard Gelatin /Cellulose Capsule shells (Printed/Unprinted), Pharma Dosage Forms (Pharma/Neutraceutical).
2 Units: Bengaluru/ Puducherry (Total capacity: 16 Bn capsules p.a.) Capex for increasing up to 24 Bn p.a.
Exports >20 Countries. For FY22 contributed 19% of Sales.
~15% of Clients engaged >10 years.
~2-3% of Sales in R& yrly.
Growing Sales & Profitability: Qtrly / yearly Basis.
Growing TNW. Sound Leverage. Improving WC Cycle.
Sharp Improvement in RoA/RoCE/RoE (in Double Digits) for FY22 vs. FY21
CF from Ops +ve.
Concern:
Moderation in liquidity position as well as capital structure.
Low C&CE of Rs.4 Crs (Jun’22)
*Do Your Own Research as Well. This is Just an Opinion.*
Happy Investing :)
P&F Pattern: Monthly Basis
Morning Star: Monthly Basis
*With Upside, Trail SL*
*Book Profit as per Risk Appetite*
Snapshot
Estab. in ‘93, Mfgs. Hard Gelatin /Cellulose Capsule shells (Printed/Unprinted), Pharma Dosage Forms (Pharma/Neutraceutical).
2 Units: Bengaluru/ Puducherry (Total capacity: 16 Bn capsules p.a.) Capex for increasing up to 24 Bn p.a.
Exports >20 Countries. For FY22 contributed 19% of Sales.
~15% of Clients engaged >10 years.
~2-3% of Sales in R& yrly.
Growing Sales & Profitability: Qtrly / yearly Basis.
Growing TNW. Sound Leverage. Improving WC Cycle.
Sharp Improvement in RoA/RoCE/RoE (in Double Digits) for FY22 vs. FY21
CF from Ops +ve.
Concern:
Moderation in liquidity position as well as capital structure.
Low C&CE of Rs.4 Crs (Jun’22)
*Do Your Own Research as Well. This is Just an Opinion.*
Happy Investing :)
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.